June 19 – National Research Council – Press Release
The National Research Council of Canada (NRC) and Augurex Life Sciences Corp. are proud to announce a collaborative agreement to develop new treatments for rheumatoid arthritis through personalized medicine. By combining their research and development expertise, NRC and Augurex will generate and characterize antibodies with therapeutic benefits in preclinical models of rheumatoid arthritis. Call 613-991-1431.